These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35533581)

  • 1. Synthesis, antimicrobial, molecular docking and molecular dynamics studies of lauroyl thymidine analogs against SARS-CoV-2: POM study and identification of the pharmacophore sites.
    Anowar Hosen M; Sultana Munia N; Al-Ghorbani M; Baashen M; Almalki FA; Ben Hadda T; Ali F; Mahmud S; Abu Saleh M; Laaroussi H; Kawsar SMA
    Bioorg Chem; 2022 Aug; 125():105850. PubMed ID: 35533581
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Hosen MA; Qais FA; Chtita S; Rahman IA; Almehdi AM; Ali F; Almalki FA; Hadda TB; Laaroussi H; Kawsar SMA
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(11):877-918. PubMed ID: 37235455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antimicrobial, SAR, PASS, molecular docking, molecular dynamics and pharmacokinetics studies of 5'-
    Munia NS; Hosen MA; Azzam KMA; Al-Ghorbani M; Baashen M; Hossain MK; Ali F; Mahmud S; Shimu MSS; Almalki FA; Hadda TB; Laaroussi H; Naimi S; Kawsar SMA
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):1036-1083. PubMed ID: 35797068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Antimicrobial, Anticancer, PASS, Molecular Docking, Molecular Dynamic Simulations & Pharmacokinetic Predictions of Some Methyl β-D-Galactopyranoside Analogs.
    Amin MR; Yasmin F; Hosen MA; Dey S; Mahmud S; Saleh MA; Emran TB; Hasan I; Fujii Y; Yamada M; Ozeki Y; Kawsar SMA
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34834107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations.
    Amin MR; Yasmin F; Dey S; Mahmud S; Saleh MA; Emran TB; Hasan I; Rajia S; Ogawa Y; Fujii Y; Yamada M; Ozeki Y; Kawsar SMA
    Glycoconj J; 2022 Apr; 39(2):261-290. PubMed ID: 35037163
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Matin MM; Uzzaman M; Chowdhury SA; Bhuiyan MMH
    J Biomol Struct Dyn; 2022 May; 40(8):3668-3680. PubMed ID: 33297848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors.
    Achutha AS; Pushpa VL; Suchitra S
    J Proteome Res; 2020 Nov; 19(11):4706-4717. PubMed ID: 32960061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Cinnamoyl-Substituted Mannopyranosides: Synthesis, Evaluation of Antimicrobial Properties, and Molecular Docking Studies Targeting H5N1 Influenza A Virus.
    Akter S; Alhatlani BY; Abdallah EM; Saha S; Ferdous J; Hossain ME; Ali F; Kawsar SMA
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Mohammad T; Shamsi A; Anwar S; Umair M; Hussain A; Rehman MT; AlAjmi MF; Islam A; Hassan MI
    Virus Res; 2020 Oct; 288():198102. PubMed ID: 32717346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, In Silico and POM Studies for the Identification of the Pharmacophore Sites of Benzylidene Derivatives.
    Hosen MI; Mukhrish YE; Jawhari AH; Celik I; Erol M; Abdallah EM; Al-Ghorbani M; Baashen M; Almalki FA; Laaroussi H; Hadda TB; Kawsar SMA
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
    Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
    Molecules; 2020 May; 25(11):. PubMed ID: 32485894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
    Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
    PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
    Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
    Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum chemical insight into molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT-IR, FT-Raman), drug likeness and molecular docking of the novel anti COVID-19 molecule 2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide - dimer.
    Mary SJJ; Siddique MUM; Pradhan S; Jayaprakash V; James C
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Jan; 244():118825. PubMed ID: 32866803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
    Elkaeed EB; Eissa IH; Elkady H; Abdelalim A; Alqaisi AM; Alsfouk AA; Elwan A; Metwaly AM
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.
    Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G
    Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation.
    Abdelrheem DA; Ahmed SA; Abd El-Mageed HR; Mohamed HS; Rahman AA; Elsayed KNM; Ahmed SA
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2020; 55(11):1373-1386. PubMed ID: 32998618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2.
    Kodchakorn K; Poovorawan Y; Suwannakarn K; Kongtawelert P
    J Mol Graph Model; 2020 Dec; 101():107717. PubMed ID: 32861974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.